- Report
- April 2025
- 110 Pages
Global
From €5190EUR$5,950USD£4,520GBP
- Report
- January 2026
- 181 Pages
Global
From €3436EUR$3,939USD£2,992GBP
- Report
- January 2026
- 185 Pages
Global
From €3925EUR$4,500USD£3,419GBP
- Report
- February 2026
- 173 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- June 2025
- 210 Pages
Global
From €4357EUR$4,995USD£3,795GBP
- Report
- November 2025
- 160 Pages
Global
From €3446EUR$3,950USD£3,001GBP
- Report
- July 2025
- 266 Pages
Global
From €3925EUR$4,500USD£3,419GBP
- Report
- October 2025
- 88 Pages
Middle East
From €4231EUR$4,850USD£3,684GBP
- Report
- May 2025
- 195 Pages
Global
From €5190EUR$5,950USD£4,520GBP
- Report
- July 2024
- 144 Pages
Global
From €2181EUR$2,500USD£1,899GBP
- Report
- February 2024
- 110 Pages
Global
From €4143EUR$4,750USD£3,609GBP
- Report
- March 2024
- 150 Pages
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- October 2024
- 100 Pages
Global
From €3500EUR$4,298USD£3,155GBP

The Arbovirus Testing market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of arboviruses, which are a group of viruses transmitted by arthropods such as mosquitoes, ticks, and sandflies. These viruses can cause a range of illnesses, including dengue, chikungunya, Zika, and yellow fever. Arbovirus Testing is used to diagnose and monitor these diseases, as well as to track the spread of arboviruses in a given population.
Arbovirus Testing is typically performed using molecular techniques such as PCR and RT-PCR, as well as serological methods such as ELISA and immunofluorescence. These tests are available from a variety of companies, including Abbott, Bio-Rad, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more